Atossa Therapeutics, Inc. (ATOS) vs Tevogen Bio Holdings Inc. (TVGN)
A side-by-side comparison of Atossa Therapeutics, Inc. and Tevogen Bio Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATOS
Atossa Therapeutics, Inc.
$2.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TVGN
Tevogen Bio Holdings Inc.
$6.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ATOS vs TVGN
growth of $100 · dividends reinvested · last 5yATOS -90.5% (-37.6%/yr)TVGN -98.7% (-57.9%/yr)ATOS compounded faster over this window
Log scale — wide-divergence pair
ATOS TVGN
ATOS vs TVGN: by the numbers
- •TVGN is the larger company ($27M vs $24M market cap).
Metrics side by side
Valuation
| Metric | ATOS | TVGN |
|---|---|---|
| P/B ratio | 0.91 | N/A |
Profitability
| Metric | ATOS | TVGN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -140.55% | N/A |
| ROIC | -146.30% | -3850.16% |
Growth (annualized)
| Metric | ATOS | TVGN |
|---|---|---|
| Total return CAGR (5Y) | -44.50% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.